Biodegradable poly(lactic-co-glycolic acid) nanoparticles carrying a small molecule immunomodulatory agent called rapamycin can help patients become more tolerant to biologic drugs. This is the new finding from researchers at Selecta Biosciences, Inc. in Watertown, Massachusetts, who say that the combination could help prevent the formation of antidrug antibodies in patients and even allow them to benefit from new types of treatment, such as gene therapy……..
http://nanotechweb.org/cws/article/tech/65778
